Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.

M.D. Wissing; J. Mendonca; M.S.Q. Kortenhorst; N.S. Kaelber; M. Gonzales; E. Kim; H. Hammers; P.J. van Diest; M.A. Carducci; S.K. Kachhap

Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.

Translated title of the contribution: Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.

M.D. Wissing, J. Mendonca, M.S.Q. Kortenhorst, N.S. Kaelber, M. Gonzales, E. Kim, H. Hammers, P.J. van Diest, M.A. Carducci, S.K. Kachhap

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.
Original language	Undefined/Unknown
Pages (from-to)	4279-4293
Number of pages	15
Journal	FASEB Journal
Volume	27
Issue number	10
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23884428

Cite this

Wissing, M. D., Mendonca, J., Kortenhorst, M. S. Q., Kaelber, N. S., Gonzales, M., Kim, E., Hammers, H., van Diest, P. J., Carducci, M. A., & Kachhap, S. K. (2013). Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors. FASEB Journal, 27(10), 4279-4293. http://www.ncbi.nlm.nih.gov/pubmed/23884428

@article{9c1a7c7df7d54c23b726a55a6ceaedfc,

title = "Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.",

author = "M.D. Wissing and J. Mendonca and M.S.Q. Kortenhorst and N.S. Kaelber and M. Gonzales and E. Kim and H. Hammers and {van Diest}, P.J. and M.A. Carducci and S.K. Kachhap",

year = "2013",

language = "Undefined/Unknown",

volume = "27",

pages = "4279--4293",

journal = "FASEB Journal",

issn = "0892-6638",

publisher = "John Wiley & Sons Inc.",

number = "10",

}

Wissing, MD, Mendonca, J, Kortenhorst, MSQ, Kaelber, NS, Gonzales, M, Kim, E, Hammers, H, van Diest, PJ, Carducci, MA & Kachhap, SK 2013, 'Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.', FASEB Journal, vol. 27, no. 10, pp. 4279-4293. <http://www.ncbi.nlm.nih.gov/pubmed/23884428>

TY - JOUR

T1 - Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.

AU - Wissing, M.D.

AU - Mendonca, J.

AU - Kortenhorst, M.S.Q.

AU - Kaelber, N.S.

AU - Gonzales, M.

AU - Kim, E.

AU - Hammers, H.

AU - van Diest, P.J.

AU - Carducci, M.A.

AU - Kachhap, S.K.

PY - 2013

Y1 - 2013

M3 - Article

SN - 0892-6638

VL - 27

SP - 4279

EP - 4293

JO - FASEB Journal

JF - FASEB Journal

IS - 10

ER -